Showing results (1-10 of 75) with videos related to
Sort By:
Pageof 8
Acta Paediatrica (Oslo, Norway : 1992)|March 30, 2007
Animal models for mucopolysaccharidosis disorders and their clinical relevanceMark E HaskinsExpert Opinion on Biological Therapy|August 31, 2007
Gene therapy for mucopolysaccharidosisKatherine P Ponder, Mark E HaskinsActa Paediatrica (Oslo, Norway : 1992)|May 28, 2008
CNS-directed gene therapy for lysosomal storage diseasesMark S Sands, Mark E HaskinsVeterinary Journal (London, England : 1997)|November 7, 2006
Inherited metabolic disease in companion animals: searching for nature's mistakesAdrian C Sewell, Mark E Haskins, Urs GigerVeterinary Clinical Pathology|November 6, 2012
Dried blood spots for the enzymatic diagnosis of lysosomal storage diseases in dogs and catsAdrian C Sewell, Mark E Haskins, Urs GigerHeart and Metabolism : Management of the Coronary Patient|March 4, 2016
Gene therapy for cardiovascular manifestations of lysosomal storage diseasesMeg M Sleeper, Mark E Haskins, Katherine P PonderThe Journal of Gene Medicine|May 11, 2004
Gene therapy for lysosomal storage diseases: the lessons and promise of animal modelsN Matthew Ellinwood, Charles H Vite, Mark E HaskinsBlood|September 13, 2003
Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogsJun Zhang, Lingfei Xu, Mark E Haskins, et al.Chemical Senses|April 1, 2005
Evidence for multiple calcium response mechanisms in mammalian olfactory receptor neuronsGeorge Gomez, Fritz W Lischka, Mark E Haskins, et al.Pediatric Research|March 5, 2005
Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal modelsCalogera M Simonaro, Marina D'Angelo, Mark E Haskins, et al.Pageof 8